| Dokumendiregister | Ravimiamet |
| Viit | REP-1/2186-1 |
| Registreeritud | 29.04.2025 |
| Sünkroonitud | 30.04.2025 |
| Liik | Sissetulev kiri |
| Funktsioon | REP Euroopa Farmakopöaga seotud asjaajamine |
| Sari | REP-1 Euroopa Farmakopöa alane kirjavahetus |
| Toimik | REP-1/2025 |
| Juurdepääsupiirang | Avalik |
| Juurdepääsupiirang | |
| Adressaat | European Directorate for the Quality of Medicines & HealthCare |
| Saabumis/saatmisviis | European Directorate for the Quality of Medicines & HealthCare |
| Vastutaja | Signe Leito (RA, Peadirektori asetäitja valdkond, Labor) |
| Originaal | Ava uues aknas |
1
Signe Leito
Saatja: [email protected] Saatmisaeg: kolmapäev, 23. aprill 2025 16:53 Adressaat: Signe Leito Teema: Proposal to add a new monograph on Treosulfan to the Ph. Eur. work programme: EDQM-2025-01741-mail
Please make sure to include in any reply our mail reference: EDQM-2025-01741-mail **************************************************************************** European Pharmacopoeia Commission Secretariat RZ/PH/ 2025-01671L Strasbourg, 23/04/2025 SI/mk
LETTER FOR THE ATTENTION OF THE NPAs Copy: Presidium
Dear Colleagues,
Please find below the link to a survey being carried out concerning the proposed addition of the monograph Treosulfan to the work programme of group 10B:
In order to have access to the survey, please copy and paste this link into your Internet browser:
https://survey.edqm.eu/index.php?r=survey/index&sid=382586&lang=en Deadline for replies: 23 May 2025.
With kind regards,
On behalf of Sylvina Iossiphova
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada.
2
Mireille Kopf Secretarial Assistant European Pharmacopoeia Department EDQM - Council of Europe Tel.: +33 (0)3 88 41 28 53 / Fax: +33 (0)3 88 41 27 71 https://www.edqm.eu / https://store.edqm.eu Stay connected with the EDQM **************************************************************************** Please make sure to include in any reply our mail reference: EDQM-2025-01741-mail